- Home
- NLSP vs LRHC Comparison
NLSP vs LRHC Comparison
Compare NLSP & LRHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- LRHC
- Stock Information
- Founded
- NLSP 2015
- LRHC 2004
- Country
- NLSP Switzerland
- LRHC United States
- Employees
- NLSP N/A
- LRHC N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- LRHC
- Sector
- NLSP Health Care
- LRHC
- Exchange
- NLSP Nasdaq
- LRHC Nasdaq
- Market Cap
- NLSP 5.8M
- LRHC 5.3M
- IPO Year
- NLSP 2021
- LRHC 2023
- Fundamental
- Price
- NLSP $1.62
- LRHC $0.15
- Analyst Decision
- NLSP
- LRHC
- Analyst Count
- NLSP 0
- LRHC 0
- Target Price
- NLSP N/A
- LRHC N/A
- AVG Volume (30 Days)
- NLSP 26.4K
- LRHC 13.5M
- Earning Date
- NLSP 05-27-2025
- LRHC 05-27-2025
- Dividend Yield
- NLSP N/A
- LRHC N/A
- EPS Growth
- NLSP N/A
- LRHC N/A
- EPS
- NLSP N/A
- LRHC N/A
- Revenue
- NLSP N/A
- LRHC $69,448,786.00
- Revenue This Year
- NLSP N/A
- LRHC N/A
- Revenue Next Year
- NLSP N/A
- LRHC N/A
- P/E Ratio
- NLSP N/A
- LRHC N/A
- Revenue Growth
- NLSP N/A
- LRHC 118.67
- 52 Week Low
- NLSP $1.30
- LRHC $0.09
- 52 Week High
- NLSP $18.40
- LRHC $3.36
- Technical
- Relative Strength Index (RSI)
- NLSP 53.77
- LRHC 47.22
- Support Level
- NLSP $1.58
- LRHC $0.12
- Resistance Level
- NLSP $1.75
- LRHC $0.16
- Average True Range (ATR)
- NLSP 0.10
- LRHC 0.01
- MACD
- NLSP 0.01
- LRHC 0.00
- Stochastic Oscillator
- NLSP 55.73
- LRHC 64.78
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.